Abstract:Abstract BACKGROUND AND AIMS Cardiovascular disease (CVD) is the leading cause of death among patients with chronic kidney disease (CKD). In addition to diabetes, hypertension, dyslipidaemia and inflammation, vascular calcification and its severity have long been recognized as a major factor in the development of CVD in patients with CKD. CKD favours gut dysbiosis, and this dysbiosis may contribute to the aggravation of CVD, inflammation, and vascular calcification in CKD. Therefore, our aim was to study the potential interconnection between vascular calcification, mortality risk, and the gut microbiome in CKD patients on peritoneal dialysis (PD). METHOD A group of 44 CKD patients on PD was evaluated concerning major inflammatory markers and key players of CKD-mineral bone disorder. Vascular calcification severity was assessed by the Adragao score, and all-cause mortality risk was assessed using the Charlson comorbidity index. Gut microbiome profile was obtained by sequencing the V3–V4 region of 16S rRNA. RESULTS The global mean of the Adragao score of our CKD-PD patients was 2.98 ± 2.74, including 26.1% with no vascular calcification (Adragao score = 0), 30.4% with moderate vascular calcification (Adragao score of 1 or 2), and 39.1% presenting severe vascular calcification (Adragao score higher than 2). When comparing CKD-PD patients with moderate or severe vascular calcification with CKD-PD patients with no vascular calcification, we found statistically significant differences regarding age (47.7 ± 11.5 versus 59.4 ± 8.8; P < 0.01), sex (% male 33.3% versus 78.1%; P = 0.011), total Kt/V (urea) (2.6 ± 0.6 versus 2.1 ± 0.4; P = 0.04) and history of diabetes mellitus (8.3% versus 48.8%; P = 0.035). No differences were found regarding the expression of inflammation markers between the two groups. When vascular calcification severity was correlated with all-cause mortality risk scored by the Charlson comorbidity index, we observed a positive significant correlation between these two factors (Spearman correlation, correlation coefficient = 0.538; P < 0.001). When comparing PD patients with and without vascular calcification, no significant differences were found regarding gut microbiome profile. Nonetheless, relative changes of specific taxa were observed, namely regarding Coprobacter, Coprococcus 3, Lactobacillus and Eubacterium eligens group in the gut microbiome. Among these taxonomic differences, patients with different Charlson comorbidity index values also demonstrated changes in the Eubacterium eligens group in the gut microbiome. The Adragao score and the Charlson index were positively correlated. CONCLUSION There is an association between vascular calcification and mortality risk in CKD patients on PD. We have found small differences in some specific taxa when comparing the gut microbiomes of CKD-PD patients with and without vascular calcification. Future studies exploring the role of these bacterial groups in the increased risk of vascular calcification, mortality and CVD in CKD-PD patients are of extreme relevance to ensure the health and well-being of these patients.

Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis

Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis

Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis

Studies on the prevalence and influence factors of vascular calcification in maintenance peritoneal dialysis patients

Plasma Osteoprotegerin Is Associated with Mortality in Hemodialysis Patients

Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification

Associated Factors of Osteoporosis and Vascular Calcification in Patients Awaiting Kidney Transplantation.

High Alkaline Phosphatase and Low Intact Parathyroid Hormone Associate with Worse Clinical Outcome in Peritoneal Dialysis Patients

Study on the Prevalence of Vascular Calcification in Different Types of Arteries and Influencing Factors in Maintenance Peritoneal Dialysis Patients

Evolution of cardiovascular calcification and clinical significance in peritoneal dialysis patients

Relationship between Vascular Calcification, Protein-Energy Wasting Syndrome, and Sarcopenia in Maintenance Automated Peritoneal Dialysis

MO737: Vascular Calcification and the Gut Microbiome in Chronic Kidney Disease Patients on Peritoneal Dialysis

Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4

Vascular Calcification and Calciphylaxis in Peritoneal Dialysis Patients

P1418BONE-DERIVED HORMONES, MINERAL METABOLISM, CARDIOVASCULAR DISEASE AND PATIENT OUTCOME IN END-STAGE RENAL PATIENTS

Vascular calcification inhibitors and cardiovascular events in peritoneal dialysis patients

Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study

[Osteopontin, platelet-derived growth factor and bone morphogenetic protein-7 in children with chronic kidney disease on renal replacement therapy--preliminary results]

Interrelations among Vascular Calcification, Bone Density, Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor Kb Ligand in Hemodialysis Patients

Analysis of factors influencing vascular calcification in peritoneal dialysis patients and their impact on long-term prognosis

De novo development of heart valve calcification in incident peritoneal dialysis patients